An independent two-stage DCF analysis by a frontier AI model.
The Clorox Company is the epitome of a defensive consumer staple. While its products lack the glamour of high-tech innovation, the sheer predictability of consumer demand for bleach, trash bags (Glad), and salad dressing (Hidden Valley) creates a formidable, cash-generating machine. The recent struggles with volume declines due to inflation-weary consumers trading down to private labels are a cyclical headwind, not a structural impairment of its immense brand equity.
The transformative $2.25 billion acquisition of GOJO Industries (makers of Purell) is a masterstroke that solidifies Clorox's dominance in the professional hygiene space. While the market currently frets over short-term integration risks and muted organic growth, it is undervaluing the long-term cash flow predictability this combined entity offers. At current levels, investors are acquiring a 'Dividend Aristocrat' with a wide economic moat at a reasonable discount to its intrinsic value.
A 5.0% growth rate assumes sluggish organic volume growth offset by continued pricing actions and the highly accretive addition of GOJO Industries' cash flows to the professional segment.
A relatively low 7.5% discount rate reflects Clorox's incredibly stable, recession-resistant cash flows and its status as a defensive consumer staple with low beta.
A 2.5% terminal rate aligns with long-term global population and GDP growth, standard for a mature, dominant consumer packaged goods manufacturer.
Intrinsic value per share under varying discount rate and terminal growth rate assumptions.
| WACC ↓ / Terminal → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 1.5% | $153.00 | $122.40 | $102.00 | $87.43 | $76.50 |
| 2.0% | $174.86 | $136.00 | $111.27 | $94.15 | $81.60 |
| 2.5% | $204.00 | $153.00 | $122.40 | $102.00 | $87.43 |
| 3.0% | $244.80 | $174.86 | $136.00 | $111.27 | $94.15 |
| 3.5% | $306.00 | $204.00 | $153.00 | $122.40 | $102.00 |
■ Undervalued vs current price ■ Overvalued vs current price
Clorox boasts a wide moat anchored by dominant brand equity in household staples. The massive recent acquisition of Purell maker GOJO Industries significantly bolsters its position in professional hygiene and health. While navigating near-term private label pressure and supply chain normalization, its aggressive moves to secure long-term market leadership and pricing power make it a compelling, defensive prospect.
Momentum is strong following the blockbuster acquisition of GOJO (Purell), though core consumer volumes face headwinds from cautious consumer spending and private label alternatives.
Clorox possesses a wide moat based entirely on intangible assets—specifically, deeply entrenched consumer brand preference and unrivaled retail shelf space dominance.
Sentiment is mixed: the market loves the defensive dividend profile but remains cautious about volume declines and the integration risks of a multi-billion dollar acquisition.
Strategically, yes. It gives Clorox a massive presence in the high-margin, sticky professional and healthcare hygiene markets, complementing its consumer retail dominance.
Years of necessary price hikes to combat inflation have pushed some budget-conscious consumers to opt for cheaper, generic store brands (private label) over premium Clorox products.
Clorox is a 'Dividend Aristocrat,' having increased its payout annually for decades. Its highly stable free cash flow makes the dividend very secure, even in economic downturns.
Disclaimer: The numbers presented on this page are for educational and entertainment purposes only. They are the result of a deterministic mathematical model fed with assumptions generated by an Artificial Intelligence (Gemini 3.1). This does not constitute investment advice. Always conduct your own due diligence before investing in the stock market.